DTCGF yields 4.80% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, DTCGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DTCGF + JNJ for your $10,000?
Dometic Group AB (publ), together with its subsidiaries, provides solutions for mobile living in the areas of food and beverage, climate, power and control, safety and security, and hygiene and sanitation in the Americas, Germany, Australia, the United Kingdom, France, Italy, Sweden, the Netherlands, Canada, and internationally. The company offers climate control products, such as air conditioners, awnings, blinds, windows and doors, ventilation products, heaters, furnaces, and patio rooms and tents; food and beverage products, including refrigerators, cool boxes, cooking products, and accessories; and safety and security products comprising carbon monoxide detectors, security locks, safety handrails, safes, alarm systems, and gas detectors, as well as driving support accessories. It also provides power and control solutions, which include energy and lighting, marine control, and marine steering systems products, and control devices, as well as related accessories; and hygiene and sanitation products, such as toilets, pumps, hoses, bio-degradable cleaners, and smart electronic controls, as well as related accessories. In addition, the company offers vessel controls, and fuel and system integration systems to the leisure marine industry; and marine blinds, screens, and soft furnishings for the leisure marine and yacht segments. Dometic Group AB (publ) provides its products for use in recreational vehicles, pleasure boats, workboats, trucks, cars, and others. The company was founded in 1922 and is headquartered in Solna, Sweden.
Full DTCGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.